(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MODULARCMC

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MODULARCMC

ST13

US500000099256867

Classe

35, 40, 42

Pedido

99256867

Registro

8308283

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

17

Atualização mais recente

16/06/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

35, 40, 42

Data de depósito

27/06/2025

Data de registro

16/06/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/06/2026

Última transação

16/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Supplemental Register

Fundamento do pedido

Intent to use

Primeiro uso

25/10/2024

Primeiro uso no comércio

25/10/2024

Código do desenho

4

Tipo de titular

03

Localização do titular

Oklahoma City, OK, US

Examinador

KEATING, MICHAEL P

Unidade examinadora

L10

Localização atual

TMEG LAW OFFICE 101

Titulares e representantes

Titulares

Wheeler Bio, Inc.

Representantes

Ava R. Shelby Wilson Sonsini Goodrich & Rosati

Classificação técnica

Classes Nice

Classe 35Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Business consulting services relating to product distributionoperations management serviceslogisticsreverse logisticssupply chainproduction systems and distribution solutions; Business management servicesmanaging logisticsreverse logisticssupply chain servicessupply chain visibility and synchronizationsupply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; Invoicing services; Order fulfillment services; customer services in the nature of responding to customer inquiries for others in the field of pharmaceutical product distribution and logistics; inventory control servicescomputerized business record management of pharmaceutical business data; inventory management in the field of pharmaceuticals and pharmaceutical products; computerized tracking and tracing of packages in transit; electronic customer ordering services for pharmaceuticalspharmaceutical productsmedical products and equipmentlaboratory supplies and equipment

Classe 40

Manufacture of pharmaceuticals and biopharmaceuticals to the order and specification of others; biomanufacturing for othersmanufacturing of biological products using biological organisms in the manufacturing process for the purpose of facilitating drug development; manufacturing services for others in the fields of mammalian cell line development and therapeutic antibody development; Manufacturing process consulting; contract manufacturing services of biopharmaceuticalsantibodies and recombinant proteins utilizing mammalian cell culture to the order and specification of others; manufacturing services for others in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development

Classe 42

Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; development of pharmaceuticalsbiopharmaceuticalspharmaceutical preparationsmedicinespharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical consulting and research services in the field of pharmaceuticals; consultation in the field of pharmaceutical drug delivery and dosage technologies; custom design and development of chemical reagents and biochemical assays; Biotechnology research; Chemical research; research and development services in the field of antibodies being antibody technology; biotechnology research and development services for othersmammalian cell line development and therapeutic antibody development; development and analysis services relating to the use of mammalian cell cultures in the field of biotechnology; providing medical and scientific technology research information in the field of pharmaceuticals and biopharmaceuticalsincluding discoverypreclinicalclinical drug research and development; toxicological safety testing services for pharmaceuticals and biopharmaceuticals; pharmaceutical contract development in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development; laboratory testing services in clinical research and clinical trials of innovator medicines in the pharmaceutical and biotechnology fields; ChemistryManufacturingControls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical and biopharmaceutical drug development; analytical servicesproviding Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of pharmaceutical and biopharmaceutical drug evaluation and development

Publicações

Histórico de despachos e eventos da marca no USPTO.

17 publicações encontradas

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

16/06/2026

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

16/06/2026

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

18/05/2026

IUAA

USE AMENDMENT ACCEPTED

18/05/2026

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

15/05/2026

IUAF

USE AMENDMENT FILED

15/05/2026

EAAU

TEAS AMENDMENT OF USE RECEIVED

15/05/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

15/05/2026

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

04/02/2026

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

04/02/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

18/11/2025

GNRT

NON-FINAL ACTION E-MAILED

18/11/2025

CNRT

NON-FINAL ACTION WRITTEN

18/11/2025

DOCK

ASSIGNED TO EXAMINER

17/11/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/11/2025

MAFR

APPLICATION FILING RECEIPT MAILED

27/06/2025

NWAP

NEW APPLICATION ENTERED

27/06/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MODULARCMC ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.